A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
Clinical trial NCT05455320 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05455320
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-13
- Primary completion
- 2027-07-30
- Enrollment
- 864
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.